Welcome to LookChem.com Sign In|Join Free

CAS

  • or

56105-81-8

Post Buying Request

56105-81-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56105-81-8 Usage

Uses

Anti-inflammatory; analgesic.

Check Digit Verification of cas no

The CAS Registry Mumber 56105-81-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,1,0 and 5 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 56105-81:
(7*5)+(6*6)+(5*1)+(4*0)+(3*5)+(2*8)+(1*1)=108
108 % 10 = 8
So 56105-81-8 is a valid CAS Registry Number.
InChI:InChI=1/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/t11-/m1/s1

56105-81-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R)-2-(3-Benzoylphenyl)propanoic acid

1.2 Other means of identification

Product number -
Other names R-KETOPROFEN

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56105-81-8 SDS

56105-81-8Synthetic route

C16H14O3*C17H21NO2

C16H14O3*C17H21NO2

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With hydrogenchloride In water at 10 - 35℃;98%
(RS)-ketoprofen vinyl ester
855519-35-6

(RS)-ketoprofen vinyl ester

A

(S)-ketoprofen vinyl ester
911412-01-6

(S)-ketoprofen vinyl ester

B

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With immobilized Lipozyme In 1,4-dioxane; water at 25℃; for 96h; Enzymatic reaction; optical yield given as %ee;A 90%
B n/a
(R)-2-(3-Benzoyl-phenyl)-propionic acid (R)-4,4-dimethyl-2-oxo-tetrahydro-furan-3-yl ester
156994-73-9

(R)-2-(3-Benzoyl-phenyl)-propionic acid (R)-4,4-dimethyl-2-oxo-tetrahydro-furan-3-yl ester

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With sodium carbonate In methanol; water for 2h; Ambient temperature;85%
(3R)-1-phenyl-4,4-dimethyl-2-oxopyrrolidin-3-yl (αR)-2-(3-benzoylphenyl)propionate
1019853-52-1

(3R)-1-phenyl-4,4-dimethyl-2-oxopyrrolidin-3-yl (αR)-2-(3-benzoylphenyl)propionate

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With hydrogenchloride; acetic acid In water at 120℃; for 2.5h; optical yield given as %ee;63%
(+)-α-(3-benzylphenyl)propionic acid
22161-82-6

(+)-α-(3-benzylphenyl)propionic acid

A

S-ketoprofen
22161-81-5

S-ketoprofen

B

(3-acetylphenyl)(phenyl)methanone
66067-44-5

(3-acetylphenyl)(phenyl)methanone

C

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With sodium hydroxide; potassium permanganate In water for 6h; Ambient temperature; Yield given;A n/a
B 28.4%
C n/a

A

S-ketoprofen
22161-81-5

S-ketoprofen

B

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With sodium hydroxide In water at 40℃; for 7.55h; titrisol buffer pH 8, carboxylesterase NP; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
With tris hydrochloride; S. solfataricus esterase In water at 60℃; for 32h; pH=7.0; Enzymatic reaction;
ketoprofen
22071-15-4

ketoprofen

A

S-ketoprofen
22161-81-5

S-ketoprofen

B

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With phosphate buffer; sodium dodecyl-sulfate; vancomycin at 20℃; Product distribution; electrophoretic enantioseparations, various substrates;
EtOH, TAPS/Tris buffer, pH 7.7;
lipase from Candida rugosa In 2,2,4-trimethylpentane; acetone Product distribution / selectivity; Resolution of racemate;
α-(3-benzoylphenyl)acrylic acid
74614-67-8

α-(3-benzoylphenyl)acrylic acid

A

S-ketoprofen
22161-81-5

S-ketoprofen

B

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With (-)-Diop; chloro(1,5-hexadiene)rhodium(I) dimer; hydrogen; triethylamine; benzene In ethanol under 53200 Torr; for 20h; Ambient temperature; Yield given. Title compound not separated from byproducts;
With (-)-Diop; chloro(1,5-hexadiene)rhodium(I) dimer; hydrogen; triethylamine In ethanol; benzene under 11172 - 77140 Torr; Product distribution; different solvents, without NEt3, with KOH; other object: optical yield;
2-chloroethyl ester of 2-(3-benzoylphenyl)propionic acid
114315-58-1

2-chloroethyl ester of 2-(3-benzoylphenyl)propionic acid

A

S-ketoprofen
22161-81-5

S-ketoprofen

B

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With water at 40℃; for 40h; Candida rugosa lipase, pH 5; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
With Candida rugosa lipase (Lipase OF); Tween-80 In water at 30℃; for 24h; pH=2.5; Title compound not separated from byproducts;
Conditions
ConditionsYield
With human serum albumin In water at 37℃; pH=7.4; Enzyme kinetics; Further Variations:; Reagents; Hydrolysis; Enzymatic reaction; isotonic 0.067 M phosphate buffer;

A

S-ketoprofen
22161-81-5

S-ketoprofen

B

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
Stage #1: ketoprofen chloride With (S)-(3-OH-4,4-di-Me-2-oxopyrrolidin-1-yl)CH2COOH on resin; triethylamine In tetrahydrofuran at 0℃;
Stage #2: With lithium hydroxide In tetrahydrofuran; water at 20℃; for 4h; Further stages. Title compound not separated from byproducts.;
(S)-2-(3-Benzoyl-phenyl)-propionic acid (S)-1-carbamoylmethyl-4,4-dimethyl-2-oxo-pyrrolidin-3-yl ester
362470-63-1

(S)-2-(3-Benzoyl-phenyl)-propionic acid (S)-1-carbamoylmethyl-4,4-dimethyl-2-oxo-pyrrolidin-3-yl ester

A

S-ketoprofen
22161-81-5

S-ketoprofen

B

R-ketoprofen
56105-81-8

R-ketoprofen

C

(S)-(3-hydroxy-4,4-dimethyl-2-oxopyrrolidin-1-yl)acetamide

(S)-(3-hydroxy-4,4-dimethyl-2-oxopyrrolidin-1-yl)acetamide

Conditions
ConditionsYield
With lithium hydroxide In tetrahydrofuran; water at 20℃; for 1h;
(R)-(-)-2-(3-benzoylphenyl)propionic acid ethyl ester
136656-96-7

(R)-(-)-2-(3-benzoylphenyl)propionic acid ethyl ester

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With novozyme 435 In water; acetonitrile at 45℃; for 45h;360 mg
ketoprofen
22071-15-4

ketoprofen

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Novozyme 435 / toluene / 2 h / 45 °C
2: 360 mg / Novozyme 435 / acetonitrile; H2O / 45 h / 45 °C
View Scheme
Multi-step reaction with 3 steps
1.1: oxalyl chloride / 12 h / 40 °C
2.1: rink amide linker modified polystyrene grafted crowns; piperidine; benzotriazolyloxy-tris(dimethylamino)phosphonium(1+) PF6(1-) / diisopropylethylamine / dimethylformamide / 12 h / 20 °C
2.2: triethylamine / tetrahydrofuran / 12 h / 0 °C
2.3: 104 mg / trifluoroacetic acid / CH2Cl2 / 0.67 h
3.1: LiOH / tetrahydrofuran; H2O / 1 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1.1: oxalyl chloride / 12 h / 40 °C
2.1: triethylamine; (S)-(3-OH-4,4-di-Me-2-oxopyrrolidin-1-yl)CH2COOH on resin / tetrahydrofuran / 0 °C
2.2: LiOH*H2O / tetrahydrofuran; H2O / 4 h / 20 °C
View Scheme
R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: rink amide linker modified polystyrene grafted crowns; piperidine; benzotriazolyloxy-tris(dimethylamino)phosphonium(1+) PF6(1-) / diisopropylethylamine / dimethylformamide / 12 h / 20 °C
1.2: triethylamine / tetrahydrofuran / 12 h / 0 °C
1.3: 104 mg / trifluoroacetic acid / CH2Cl2 / 0.67 h
2.1: LiOH / tetrahydrofuran; H2O / 1 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: 99.5 percent Spectr. / Et3N / toluene / -10 °C
2: 85 percent / Na2CO3 / methanol; H2O / 2 h / Ambient temperature
View Scheme
ethyl α-(3-benzoylphenyl)acrylate
75116-78-8

ethyl α-(3-benzoylphenyl)acrylate

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 93 percent / 3percent KOH/H2O / tetrahydrofuran / 24 h / Ambient temperature
2: H2, 2/(-)-DIOP/NEt3 / ethanol; benzene / 11172 - 77140 Torr / different solvents, without NEt3, with KOH; other object: optical yield
View Scheme
ketoprofen
22071-15-4

ketoprofen

bis(1-naphthyl)methanol
62784-66-1

bis(1-naphthyl)methanol

A

(R)-ketoprofen di(1-naphthyl)methyl ester
1116086-47-5

(R)-ketoprofen di(1-naphthyl)methyl ester

B

(S)-ketoprofen di(1-naphthyl)methyl ester

(S)-ketoprofen di(1-naphthyl)methyl ester

C

S-ketoprofen
22161-81-5

S-ketoprofen

D

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With (R)-(+)-2-phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole; p-Methoxybenzoic anhydride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 12h; Resolution of racemate; optical yield given as %ee;
With (-)-(S)-β-Np-BTM; 2,2-dimethylpropanoic anhydride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 12h; Inert atmosphere; Resolution of racemate; optical yield given as %ee; enantioselective reaction;
With benzoic acid anhydride; N-ethyl-N,N-diisopropylamine; (R)-(+)-2-phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole In dichloromethane at 20℃; for 6h; Product distribution / selectivity; Resolution of racemate;A n/a
B n/a
C n/a
D n/a
(R,S)-N-ketoprofenyl-1,2,4-triazole
1213788-21-6

(R,S)-N-ketoprofenyl-1,2,4-triazole

A

(S)-N-ketoprofenyl-1,2,4-triazole
1213788-33-0

(S)-N-ketoprofenyl-1,2,4-triazole

B

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With Novozym 435; water In tert-butyl methyl ether at 45℃; Kinetics; Solvent; Concentration;

A

R-ketoprofen
56105-81-8

R-ketoprofen

B

methyl (2S)-2-(3-benzoylphenyl)propanoate

methyl (2S)-2-(3-benzoylphenyl)propanoate

C

(R)-(-)-2-(3-benzoylphenyl)propionic acid methyl ester
81601-93-6

(R)-(-)-2-(3-benzoylphenyl)propionic acid methyl ester

Conditions
ConditionsYield
With Novozym 435; water In tert-butyl methyl ether at 45℃; Kinetics; Solvent; Concentration; optical yield given as %ee;
4-nitrophenyl 2-(3-benzoylphenyl)propanoate

4-nitrophenyl 2-(3-benzoylphenyl)propanoate

A

C22H17NO5

C22H17NO5

B

C22H17NO5

C22H17NO5

C

S-ketoprofen
22161-81-5

S-ketoprofen

D

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
Stage #1: 4-nitrophenyl 2-(3-benzoylphenyl)propanoate With Pseudomonas aeruginosa lipase Met16Ala/Leu17Phe/Leu162Asn mutant In acetonitrile at 30℃; for 1.5h; pH=7.5; aq. phosphate buffer; Resolution of racemate; Enzymatic reaction;
Stage #2: With hydrogenchloride In water; acetonitrile enantioselective reaction;
ketoprofen
22071-15-4

ketoprofen

9,9‘-bis-phenanthrylmethanol
110282-71-8

9,9‘-bis-phenanthrylmethanol

A

(R)-ketoprofen di(9-phenanthryl)methyl ester
1187670-14-9

(R)-ketoprofen di(9-phenanthryl)methyl ester

B

(S)-ketoprofen di(9-phenanthryl)methyl ester

(S)-ketoprofen di(9-phenanthryl)methyl ester

C

S-ketoprofen
22161-81-5

S-ketoprofen

D

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With p-Methoxybenzoic anhydride; N-ethyl-N,N-diisopropylamine; (R)-(+)-2-phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole In dichloromethane at 20℃; for 12h; Product distribution / selectivity; Resolution of racemate;A n/a
B n/a
C n/a
D n/a
With (R)-(+)-2-phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole; p-Methoxybenzoic anhydride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 12h; optical yield given as %ee; enantioselective reaction;
C19H15BrN2O2
1268613-74-6

C19H15BrN2O2

A

C19H15BrN2O2
1268614-30-7

C19H15BrN2O2

B

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With Candida antarctica lipase B; water In tert-butyl methyl ether at 45℃; for 2h; Resolution of racemate; Enzymatic reaction; optical yield given as %ee; enantioselective reaction;
C26H22O4

C26H22O4

A

S-ketoprofen
22161-81-5

S-ketoprofen

B

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With copper(l) chloride In methanol at 40℃; Inert atmosphere; optical yield given as %ee;
2-methyl-2-(3-benzoylphenyl)malonic acid
150360-24-0

2-methyl-2-(3-benzoylphenyl)malonic acid

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With Mesorhizobium sp. BNC1 arylmalonate decarboxylase Enzymatic reaction; enantioselective reaction;
ethyl 2-<3-benzoylphenyl>propionate
60658-04-0

ethyl 2-<3-benzoylphenyl>propionate

A

S-ketoprofen
22161-81-5

S-ketoprofen

B

R-ketoprofen
56105-81-8

R-ketoprofen

Conditions
ConditionsYield
With Thermotoga maritima esterase Tm1160 In aq. acetate buffer at 70℃; for 32h; pH=5.5; Enzymatic reaction; enantioselective reaction;A n/a
B n/a
ethyl 2-<3-benzoylphenyl>propionate
60658-04-0

ethyl 2-<3-benzoylphenyl>propionate

A

S-ketoprofen
22161-81-5

S-ketoprofen

B

R-ketoprofen
56105-81-8

R-ketoprofen

C

methyl (2S)-2-(3-benzoylphenyl)propanoate

methyl (2S)-2-(3-benzoylphenyl)propanoate

D

(R)-(-)-2-(3-benzoylphenyl)propionic acid methyl ester
81601-93-6

(R)-(-)-2-(3-benzoylphenyl)propionic acid methyl ester

Conditions
ConditionsYield
With Yarrowia lipolytica Lip2p lipase In decane at 20℃; for 100h; Kinetics; Enzymatic reaction; enantioselective reaction;
ethyl 2-<3-benzoylphenyl>propionate
60658-04-0

ethyl 2-<3-benzoylphenyl>propionate

A

R-ketoprofen
56105-81-8

R-ketoprofen

B

methyl (2S)-2-(3-benzoylphenyl)propanoate

methyl (2S)-2-(3-benzoylphenyl)propanoate

Conditions
ConditionsYield
With Candida rugose lipase CRL4 10X In decane at 20℃; for 100h; Kinetics; Enzymatic reaction; enantioselective reaction;
propan-1-ol
71-23-8

propan-1-ol

R-ketoprofen
56105-81-8

R-ketoprofen

(R)-2-(3-Benzoyl-phenyl)-propionic acid propyl ester

(R)-2-(3-Benzoyl-phenyl)-propionic acid propyl ester

Conditions
ConditionsYield
In 2,2,4-trimethylpentane at 30℃; lyophilized crude lipase (olive oil);85%
R-ketoprofen
56105-81-8

R-ketoprofen

1-amino-3-(dimethylamino)propane
109-55-7

1-amino-3-(dimethylamino)propane

(R)-2-[(3-benzoyl)phenyl]-N-[3-(dimethylamino)propyl]propionamide

(R)-2-[(3-benzoyl)phenyl]-N-[3-(dimethylamino)propyl]propionamide

Conditions
ConditionsYield
Stage #1: R-ketoprofen With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 0.5h;
Stage #2: 1-amino-3-(dimethylamino)propane In dichloromethane at 20℃;
75%
methanesulfonamide
3144-09-0

methanesulfonamide

R-ketoprofen
56105-81-8

R-ketoprofen

DF 1661

DF 1661

Conditions
ConditionsYield
Stage #1: R-ketoprofen With 1,1'-carbonyldiimidazole In dichloromethane at 0 - 5℃; for 2h;
Stage #2: methanesulfonamide With 1,2-diazabicyclo[5.4.0]undec-7-ene In dichloromethane for 4h;
74%
epicholesterol
474-77-1

epicholesterol

R-ketoprofen
56105-81-8

R-ketoprofen

epi-cholesteryl (R)-2-(3-benzoylphenyl)propionate
913843-20-6

epi-cholesteryl (R)-2-(3-benzoylphenyl)propionate

Conditions
ConditionsYield
Stage #1: R-ketoprofen With dicyclohexyl-carbodiimide In dichloromethane at 0℃; for 0.5h;
Stage #2: epicholesterol With dmap In dichloromethane at 0℃; for 8h;
74%
R-ketoprofen
56105-81-8

R-ketoprofen

C37H48N7O18P3S

C37H48N7O18P3S

Conditions
ConditionsYield
Stage #1: R-ketoprofen With 2,6-dimethylpyridine; chloroformic acid ethyl ester In dichloromethane at 20℃; for 1h;
Stage #2: coenzyme A With sodium hydroxide In tetrahydrofuran; water at 20℃; for 2h; pH=6.2;
methanol
67-56-1

methanol

R-ketoprofen
56105-81-8

R-ketoprofen

(R)-(-)-2-(3-benzoylphenyl)propionic acid methyl ester
81601-93-6

(R)-(-)-2-(3-benzoylphenyl)propionic acid methyl ester

Conditions
ConditionsYield
With sulfuric acid at 20℃;
With sulfuric acid at 80℃;
glycine ethyl ester hydrochloride
5680-79-5

glycine ethyl ester hydrochloride

R-ketoprofen
56105-81-8

R-ketoprofen

[(R)-2-(3-Benzoyl-phenyl)-propionylamino]-acetic acid methyl ester

[(R)-2-(3-Benzoyl-phenyl)-propionylamino]-acetic acid methyl ester

Conditions
ConditionsYield
Stage #1: R-ketoprofen With 1-hydroxybenzotriazol-hydrate; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 0 - 5℃; for 1h;
Stage #2: glycine ethyl ester hydrochloride In N,N-dimethyl-formamide at 20℃;
R-ketoprofen
56105-81-8

R-ketoprofen

(R)-2-(3-Benzoyl-phenyl)-propionyl chloride

(R)-2-(3-Benzoyl-phenyl)-propionyl chloride

Conditions
ConditionsYield
With thionyl chloride for 3h; Heating;
cholesterol
57-88-5

cholesterol

R-ketoprofen
56105-81-8

R-ketoprofen

epi-cholesteryl (R)-2-(3-benzoylphenyl)propionate
913843-20-6

epi-cholesteryl (R)-2-(3-benzoylphenyl)propionate

Conditions
ConditionsYield
Mitsunobu reaction;
R-ketoprofen
56105-81-8

R-ketoprofen

3-ethylbenzophenone
66067-43-4

3-ethylbenzophenone

Conditions
ConditionsYield
In phosphate buffer at 25℃; pH=7.4; Quantum yield; Kinetics; Further Variations:; Reagents; Photolysis;
R-ketoprofen
56105-81-8

R-ketoprofen

methyl (2R)-2-[3-(1-phenylethyl)phenyl]propanoate
875294-84-1

methyl (2R)-2-[3-(1-phenylethyl)phenyl]propanoate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: H2SO4 / 20 °C
2.1: n-BuLi / tetrahydrofuran; hexane / 3 h / 0 - 5 °C
2.2: 71 percent / tetrahydrofuran; hexane / 20 °C
3.1: H2 / Pd/C / ethanol / 18 h
View Scheme
R-ketoprofen
56105-81-8

R-ketoprofen

(R),(R',S')-2-[3-(α-methylbenzyl)phenyl]propionyl chloride
454701-83-8

(R),(R',S')-2-[3-(α-methylbenzyl)phenyl]propionyl chloride

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: H2SO4 / 20 °C
2.1: n-BuLi / tetrahydrofuran; hexane / 3 h / 0 - 5 °C
2.2: 71 percent / tetrahydrofuran; hexane / 20 °C
3.1: H2 / Pd/C / ethanol / 18 h
4.1: 0.29 g / aq. KOH / dioxane / 20 °C
5.1: SOCl2 / 8 h / Heating
View Scheme
R-ketoprofen
56105-81-8

R-ketoprofen

(2R)-2-[3-(1-phenylethyl)phenyl]propanoic acid
354904-38-4

(2R)-2-[3-(1-phenylethyl)phenyl]propanoic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: H2SO4 / 20 °C
2.1: n-BuLi / tetrahydrofuran; hexane / 3 h / 0 - 5 °C
2.2: 71 percent / tetrahydrofuran; hexane / 20 °C
3.1: H2 / Pd/C / ethanol / 18 h
4.1: 0.29 g / aq. KOH / dioxane / 20 °C
View Scheme
R-ketoprofen
56105-81-8

R-ketoprofen

methyl (2R)-2-[3-(1-phenylvinyl)phenyl]propanoate
859828-61-8

methyl (2R)-2-[3-(1-phenylvinyl)phenyl]propanoate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: H2SO4 / 20 °C
2.1: n-BuLi / tetrahydrofuran; hexane / 3 h / 0 - 5 °C
2.2: 71 percent / tetrahydrofuran; hexane / 20 °C
View Scheme
R-ketoprofen
56105-81-8

R-ketoprofen

N-{2-[3-(1-phenyl-ethyl)-phenyl]-propionyl}-methanesulfonamide

N-{2-[3-(1-phenyl-ethyl)-phenyl]-propionyl}-methanesulfonamide

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: H2SO4 / 20 °C
2.1: n-BuLi / tetrahydrofuran; hexane / 3 h / 0 - 5 °C
2.2: 71 percent / tetrahydrofuran; hexane / 20 °C
3.1: H2 / Pd/C / ethanol / 18 h
4.1: 0.29 g / aq. KOH / dioxane / 20 °C
5.1: 1,1'-carbonyldiimidazole / CH2Cl2 / 2 h / 0 - 5 °C
5.2: 30 percent / diazabicyclo[5.4.0]undec-7-ene / CH2Cl2 / 4 h
View Scheme
R-ketoprofen
56105-81-8

R-ketoprofen

[(R)-2-(3-Benzoyl-phenyl)-propionylamino]-acetic acid

[(R)-2-(3-Benzoyl-phenyl)-propionylamino]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: 1-hydroxybenzotriazole hydrate; 1,3-dicyclohexylcarbodiimide / dimethylformamide / 1 h / 0 - 5 °C
1.2: dimethylformamide / 20 °C
2.1: 0.31 g / aq. NaOH / dioxane / 20 °C
View Scheme

56105-81-8Relevant articles and documents

Reshaping the active pocket of esterase Est816 for resolution of economically important racemates

Fan, Xinjiong,Fu, Yao,Liu, Xiaolong,Zhao, Meng

, p. 6126 - 6133 (2021/09/28)

Bacterial esterases are potential biocatalysts for the production of optically pure compounds. However, the substrate promiscuity and chiral selectivity of esterases usually have a negative correlation, which limits their commercial value. Herein, an efficient and versatile esterase (Est816) was identified as a promising catalyst for the hydrolysis of a wide range of economically important substrates with low enantioselectivity. We rationally designed several variants with up to 11-fold increased catalytic efficiency towards ethyl 2-arylpropionates, mostly retaining the initial substrate scope and enantioselectivity. These variants provided a dramatic increase in efficiency for biocatalytic applications. Based on the best variant Est816-M1, several variants with higher or inverted enantioselectivity were designed through careful analysis of the structural information and molecular docking. Two stereoselectively complementary mutants, Est816-M3 and Est816-M4, successfully overcame and even reversed the low enantioselectivity, and several 2-arylpropionic acid derivatives with highEvalues were obtained. Our results offer potential industrial biocatalysts for the preparation of structurally diverse chiral carboxylic acids and further lay the foundation for improving the catalytic efficiency and enantioselectivity of esterases.

Evaluation of the Edman degradation product of vancomycin bonded to core-shell particles as a new HPLC chiral stationary phase

Hellinghausen, Garrett,Lopez, Diego A.,Lee, Jauh T.,Wang, Yadi,Weatherly, Choyce A.,Portillo, Abiud E.,Berthod, Alain,Armstrong, Daniel W.

, p. 1067 - 1078 (2018/08/01)

A modified macrocyclic glycopeptide-based chiral stationary phase (CSP), prepared via Edman degradation of vancomycin, was evaluated as a chiral selector for the first time. Its applicability was compared with other macrocyclic glycopeptide-based CSPs: TeicoShell and VancoShell. In addition, another modified macrocyclic glycopeptide-based CSP, NicoShell, was further examined. Initial evaluation was focused on the complementary behavior with these glycopeptides. A screening procedure was used based on previous work for the enantiomeric separation of 50 chiral compounds including amino acids, pesticides, stimulants, and a variety of pharmaceuticals. Fast and efficient chiral separations resulted by using superficially porous (core-shell) particle supports. Overall, the vancomycin Edman degradation product (EDP) resembled TeicoShell with high enantioselectivity for acidic compounds in the polar ionic mode. The simultaneous enantiomeric separation of 5 racemic profens using liquid chromatography-mass spectrometry with EDP was performed in approximately 3?minutes. Other highlights include simultaneous liquid chromatography separations of rac-amphetamine and rac-methamphetamine with VancoShell, rac-pseudoephedrine and rac-ephedrine with NicoShell, and rac-dichlorprop and rac-haloxyfop with TeicoShell.

Enantioselective potential of polysaccharide-based chiral stationary phases in supercritical fluid chromatography

Kucerova, Gabriela,Kalikova, Kveta,Tesarova, Eva

supporting information, p. 239 - 246 (2017/05/29)

The enantioselective potential of two polysaccharide-based chiral stationary phases for analysis of chiral structurally diverse biologically active compounds was evaluated in supercritical fluid chromatography using a set of 52 analytes. The chiral selectors immobilized on 2.5?μm silica particles were tris-(3,5-dimethylphenylcarmabate) derivatives of cellulose or amylose. The influence of the polysaccharide backbone, different organic modifiers, and different mobile phase additives on retention and enantioseparation was monitored. Conditions for fast baseline enantioseparation were found for the majority of the compounds. The success rate of baseline and partial enantioseparation with cellulose-based chiral stationary phase was 51.9% and 15.4%, respectively. Using amylose-based chiral stationary phase we obtained 76.9% of baseline enantioseparations and 9.6% of partial enantioseparations of the tested compounds. The best results on cellulose-based chiral stationary phase were achieved particularly with propane-2-ol and a mixture of isopropylamine and trifluoroacetic acid as organic modifier and additive to CO2, respectively. Methanol and basic additive isopropylamine were preferred on amylose-based chiral stationary phase. The complementary enantioselectivity of the cellulose- and amylose-based chiral stationary phases allows separation of the majority of the tested structurally different compounds. Separation systems were found to be directly applicable for analyses of biologically active compounds of interest.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56105-81-8